Overall, Western blot analysis confirmed upregulation of key sphingolipid enzymes such as SMPD3 and ASAH2, in IDH1mut glioma cells specifically, which suggested that the pathway is upregulated towards the elevating the availability of sphingosine and ceramide. The gene discussed is SMPD3; the disease is central nervous system cancer.